Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

AstraZeneca
Pharmaceuticals
GSK
Novo Nordisk
Pfizer
Roche
Johnson and Johnson
Zoetis
Eli Lilly
Novartis
Topics

Advertisement

AstraZeneca

Share

Top Latest Popular

Ada 2026: AstraZeneca advances oral GLP-1 elecoglipron into Phase III after positive trial data Scrip Pharma Intelligence 14h

Scrip Pharma Intelligence 14h

Encouraging trial results for AstraZeneca's new weight-loss pill France 24 8h

France 24 8h

Hong Kong's urban development near China border draws AstraZeneca, others Nikkei Asian Review 14h

Nikkei Asian Review 14h

STAT Plus: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials STAT 14h

STAT 14h

Advertisement

expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes Science Media Centre 14h

Science Media Centre 14h

AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial Rock Hill Herald 14h

Rock Hill Herald 14h

Advertisement

Advertisement

Latest

In the last hour

ADA: AZ reveals oral GLP-1 data in obesity, diabetes pharmaphorum 10:59

Earlier Today

Encouraging trial results for AstraZeneca's new weight-loss pill France 24 03:08

Yesterday

ADA 2026: AstraZeneca Advances Oral GLP-1 Elecoglipron Into Phase III After Positive Trial Data Scrip Pharma Intelligence 21:49 Mon, 08 Jun

expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes Science Media Centre 21:40 Mon, 08 Jun

AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial Rock Hill Herald 21:37 Mon, 08 Jun

Hong Kong's urban development near China border draws AstraZeneca, others Nikkei Asian Review 21:29 Mon, 08 Jun

STAT Plus: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials STAT 21:25 Mon, 08 Jun

Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio AstraZeneca (Press Release) 21:22 Mon, 08 Jun

Leica Biosystems announces expansion of collaboration European Pharmaceutical Manufacturer 17:09 Mon, 08 Jun

Friday

AstraZeneca Stresses Interconnected Disease Strategy In CVRM Scrip Pharma Intelligence 22:30 Fri, 05 Jun

Advertisement

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis